ScholarIQanswers from OpenAlex & ORCID
Carmen Montoto
ResearcherPublications, citations & collaboration network
Carmen Montoto is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Carmen Montoto have?
ScholarIQindexed works
Carmen Montoto has 29 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Carmen Montoto have?
ScholarIQcitation count
Carmen Montoto has 243 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Carmen Montoto?
ScholarIQh-index
Carmen Montoto has an h-index of 10 in OpenAlex.
What is the i10-index of Carmen Montoto?
ScholarIQi10-index
Carmen Montoto has an i10-index of 10 in OpenAlex.
What is the ORCID of Carmen Montoto?
ScholarIQorcid
The ORCID for Carmen Montoto is on the source record.
What is the OpenAlex record for Carmen Montoto?
ScholarIQopenalex
The OpenAlex for Carmen Montoto is on the source record.
What are the most-cited papers on Carmen Montoto?
ScholarIQmost cited works
Prevalence and characterization of breakthrough pain in patients with cancer in Spain: the CARPE-DIO study
Concepción Pérez, Ana Blasco, Á. F. Gândara, A Mañas, M. J. Rodríguez-López, Vicente Martínez, Alonso Fernández-Nistal, Carmen Montoto
Factors influencing medical treatment of heart failure patients in Spanish internal medicine departments: a national survey
Pilar Román-Sánchez, Pedro Conthe, Javier García-Alegría, J. Forteza-Rey, M. Montero, Carmen Montoto, for the Heart Failure Working Group of the Spanish Society of Internal Medicine
Clinical characteristics and prognostic factors for Crohn’s disease relapses using natural language processing and machine learning: a pilot study
Fernando Gomollón, Javier P. Gisbert, Iván Guerra, Rocío Plaza, Ramón Pajares Villarroya, Luis Moreno Almazán, Ma Carmen López Martín, Mercedes Domínguez Antonaya, María Isabel Vera Mendoza, Jesús Aparicio, Vicente Martı́nez, Ignacio Tagarro, Alonso Fernández-Nistal, Sara Lumbreras, Claudia Maté, Carmen Montoto
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an <i>in silico</i> systems biology-based approach
Enric Carcereny, Alonso Fernández-Nistal, Araceli López, Carmen Montoto, Andrea Naves, Cristina Segú-Vergés, Mireia Coma, Guillem Jorba, Baldomero Oliva, José Manuel Mas
Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate
José Ramón Gutiérrez-Casares, Javier Quintero, Guillem Jorba, Valentin Junet, Vicente Martínez, Tamara Pozo-Rubio, Baldomero Oliva, Xavier Daura, José Manuel Mas, Carmen Montoto